期刊文献+

医疗机构开展细胞治疗临床试验的思考

Reflections on the conduct of cell therapy clinical trials in medical institutes
原文传递
导出
摘要 目的本文介绍"以患者为中心细胞治疗研究管理模式",期望对国内医疗机构开展细胞治疗临床试验有所启示。方法通过总结北京大学深圳医院应对开展细胞治疗研究面临的技术评估、伦理评估风险以及规范实施等挑战的具体策略,探索建立以患者为中心的,多方共同决策的研究管理体系的相关思考与实践经验。结果"以患者为中心的细胞治疗研究管理模式"通过多方共同决策与管理,进行充分技术评估、有效伦理审查以及有组织的科研管理,确保研究结果可靠,不仅能满足患者迫切的临床治疗需求,也促进规范开展创新技术。结论"以患者为中心"的研究管理模式适用于细胞治疗临床试验,值得进一步评价与应用。 Objective This paper introduces the concepts of"patient-centered cell therapy research management model",to provide reference for domestic medical institutions which conduct cell therapy clinical trials.Methods We reviewed and summarized the experiences of conducting cell therapy at Peking University Shenzhen Hospital,including challenges and response plans regarding to the technology assessment,ethical evaluation risks and regulatory compliance.According to which,this paper aims to explore the reflections and practical experience of establishing a patient-centered,multi-stakeholder shared decision-making research management system.Results The"patient-centered cell therapy research management model"ensures the reliability of research results through multi-stakeholder engagement in decision-making and management,adequate technical evaluation,effective ethical review and harmonized scientific research management,which not only meets the urgent health needs of the patient,but also promotes the standardized development of emerging technologies.Conclusions The"patient-centered cell therapy research management model"is tailored for the cell therapy research,it is important to promote its further assessment and applications.
作者 吉萍 石宇 许卫卫 赵永胜 王涛 陈俊辉 陈芸 Ji Ping;Shi Yu;Xu Weiwei;Zhao Yongsheng;Wang Tao;Chen Junhui;Chen Yun(Shenzhen-Peking University-The Hongkong University of Science&Technology Medical Center,Shenzhen 518036,China;Peking University Shenzhen Hospital,Shenzhen 518036,China)
出处 《中华医学科研管理杂志》 2023年第1期2-6,共5页 Chinese Journal of Medical Science Research Management
基金 2016年深圳市医疗卫生"三名工程"项目(SZSM201612061) 深圳市虚拟现实临床应用公共服务平台提升项目(XMHT20190104001)。
关键词 细胞治疗 以患者为中心的试验 共同决策 Cell therapy Patient-centered clinical trials Shared decision making
  • 相关文献

参考文献12

二级参考文献79

  • 1黄梁江,陈红.干细胞的临床研究与转化[J].内科急危重症杂志,2020(2):104-108. 被引量:5
  • 2张斌,陈虎.肿瘤免疫细胞治疗的质量管理和疗效评价[J].中国肿瘤生物治疗杂志,2015,22(1):8-15. 被引量:17
  • 3Herberts CA, Kwa MS, Hermsen HP. Risk factors in the development of stem cell therapy [J]. J Transl Med, 2011, 9( 1 ) : 29-42.
  • 4Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors [J]. Cell, 2006, 126 (4): 663-676.
  • 5Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem ceils from adult human fibroblasts by defined factors [J].Cell, 2007, 131 (5): 861-872.
  • 6Amariglio N, Hirshberg A, Seheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasiapatient [J]. PLoSMed, 2009, 6 (2): e1000029.
  • 7Li H, Fan X, Kovi RC, et al, Spontaneous expression of embryonic factors and p53 point mutations in aged mesenehymal stem cells: a model of age-related tumorigenesis in mice [J]. Cancer Res, 2007, 67 (22): 10889-10898.
  • 8Torsvik A, Rosland GV, Svendsen A, et ol. Spontaneous malignant transformation of human mesenchymal stem ceils reflects cross- contamination: putting the research field on track-letter [J]. Cancer Res, 2010, 70 (15): 6393-6396.
  • 9Narva E, Autio R, Rahkonen N, et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture- induced copy number changes and loss of heterozygosity [J]. Nat Biotechnol, 2010, 28 (4): 371-377.
  • 10Garcia S, Bernad A, Martin MC, et al. Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells [J]. Exp Cell Res, 2010, 316 (9): 1648-1650.

共引文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部